{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:59:49Z","timestamp":1785527989200,"version":"3.56.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13181-026-01133-9","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:13:13Z","timestamp":1775754793000},"page":"375-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Summary of Strategies to Mitigate Intradialytic Hypotension in Poisoned Patients Requiring Extracorporeal Toxin Elimination"],"prefix":"10.1007","volume":"22","author":[{"given":"David K.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandtly","family":"Yakey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh D.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"4","key":"1133_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/ndt\/gfw456","volume":"32","author":"J Bouchard","year":"2017","unstructured":"Bouchard J, et al. Availability and cost of extracorporeal treatments for poisonings and other emergency indications: a worldwide survey. Nephrol Dial Transpl. 2017;32(4):699\u2013706.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"1133_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/sdi.12247","volume":"27","author":"J Bouchard","year":"2014","unstructured":"Bouchard J, et al. Principles and operational parameters to optimize poison removal with extracorporeal treatments. Semin Dial. 2014;27(4):371\u201380.","journal-title":"Semin Dial"},{"issue":"4","key":"1133_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/sdi.12228","volume":"27","author":"M Ghannoum","year":"2014","unstructured":"Ghannoum M, et al. A stepwise approach for the management of poisoning with extracorporeal treatments. Semin Dial. 2014;27(4):362\u201370.","journal-title":"Semin Dial"},{"issue":"3","key":"1133_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1681\/ASN.2014020222","volume":"26","author":"JE Flythe","year":"2015","unstructured":"Flythe JE, et al. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol. 2015;26(3):724\u201334.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1133_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ckj\/sfaa078","volume":"13","author":"M Kanbay","year":"2020","unstructured":"Kanbay M, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981\u201393.","journal-title":"Clin Kidney J"},{"issue":"1\u20132","key":"1133_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000503776","volume":"49","author":"B Sars","year":"2020","unstructured":"Sars B, van der Sande FM, Kooman JP. Intradialytic Hypotension: Mechanisms and Outcome. Blood Purif. 2020;49(1\u20132):158\u201367.","journal-title":"Blood Purif"},{"issue":"3","key":"1133_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ekir.2022.10.031","volume":"8","author":"A Davenport","year":"2023","unstructured":"Davenport A. Why is Intradialytic Hypotension the Commonest Complication of Outpatient Dialysis Treatments? Kidney Int Rep. 2023;8(3):405\u201318.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"1133_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12882-023-03263-6","volume":"24","author":"J Wang","year":"2023","unstructured":"Wang J, et al. Impact of frequent intradialytic hypotension on quality of life in patients undergoing hemodialysis. BMC Nephrol. 2023;24(1):209.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1133_CR9","doi-asserted-by":"publisher","first-page":"11532","DOI":"10.1038\/s41598-025-96286-y","volume":"15","author":"M Zhi","year":"2025","unstructured":"Zhi M, et al. The relationship between intradialytic hypotension and health-related quality of life in patients undergoing hemodialysis: a cross-sectional study. Sci Rep. 2025;15(1):11532.","journal-title":"Sci Rep"},{"issue":"1","key":"1133_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40635-024-00695-8","volume":"12","author":"RMC Lyrio","year":"2024","unstructured":"Lyrio RMC, et al. Predictors of intradialytic hypotension in critically ill patients undergoing kidney replacement therapy: a systematic review. Intensive Care Med Exp. 2024;12(1):106.","journal-title":"Intensive Care Med Exp"},{"key":"1133_CR11","volume-title":"Clinical Characteristics of Fatal Salicylate Poisonings. in International Congress of the EAPCCT","author":"HL Frischtak","year":"2015","unstructured":"Frischtak HL, et al. Clinical Characteristics of Fatal Salicylate Poisonings. in International Congress of the EAPCCT. Malta: St. Julian\u2019s; 2015."},{"issue":"5","key":"1133_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.7326\/0003-4819-86-5-554","volume":"86","author":"F Rodrigo","year":"1977","unstructured":"Rodrigo F, et al. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977;86(5):554\u201361.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1133_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00134-019-05707-w","volume":"45","author":"A Douvris","year":"2019","unstructured":"Douvris A, et al. Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review. Intensive Care Med. 2019;45(10):1333\u201346.","journal-title":"Intensive Care Med"},{"issue":"8","key":"1133_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.34067\/KID.0003402022","volume":"3","author":"KS Ravi","year":"2022","unstructured":"Ravi KS. High ultrafiltration rates and mortality in hemodialysis patients: current evidence and future steps. Kidney360. 2022;3(8):1293\u20135.","journal-title":"Kidney360"},{"issue":"1","key":"1133_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/0886022X.2020.1853570","volume":"43","author":"J Yu","year":"2021","unstructured":"Yu J, et al. High ultrafiltration rate induced intradialytic hypotension is a predictor for cardiac remodeling: a 5-year cohort study. Ren Fail. 2021;43(1):40\u20138.","journal-title":"Ren Fail"},{"key":"1133_CR16","volume-title":"Physiology, Baroreceptors, in StatPearls","author":"M Armstrong","year":"2025","unstructured":"Armstrong M, Moore RA. Physiology, Baroreceptors, in StatPearls. StatPearls Publishing: Treasure Island (FL); 2025."},{"issue":"1","key":"1133_CR17","first-page":"39","volume":"105","author":"MJ Kim","year":"2022","unstructured":"Kim MJ, Farrell J. Orthostatic Hypotension: A Practical Approach. Am Fam Physician. 2022;105(1):39\u201349.","journal-title":"Am Fam Physician"},{"issue":"5","key":"1133_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1172\/JCI116037","volume":"90","author":"RL Converse Jr","year":"1992","unstructured":"Converse RL Jr., et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest. 1992;90(5):1657\u201365.","journal-title":"J Clin Invest"},{"issue":"3","key":"1133_CR19","first-page":"228","volume":"13","author":"H Poorzand","year":"2021","unstructured":"Poorzand H, et al. Echocardiographic parameters in patients with and without hypotension during dialysis. J Cardiovasc Thorac Res. 2021;13(3):228\u201333.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"1","key":"1133_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.03170707","volume":"3","author":"CW McIntyre","year":"2008","unstructured":"McIntyre CW, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008;3(1):19\u201326.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1133_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000358203","volume":"39","author":"EM Ettema","year":"2014","unstructured":"Ettema EM, et al. Dialysis hypotension: a role for inadequate increase in arginine vasopressin levels? A systematic literature review and meta-analysis. Am J Nephrol. 2014;39(2):100\u20139.","journal-title":"Am J Nephrol"},{"issue":"11","key":"1133_CR22","first-page":"e20219","volume":"16","author":"SS Beladi Mousavi","year":"2014","unstructured":"Beladi Mousavi SS, Tamadon MR. Vasopressin and prevention of hypotension during hemodialysis. Iran Red Crescent Med J. 2014;16(11):e20219.","journal-title":"Iran Red Crescent Med J"},{"key":"1133_CR23","unstructured":"Wisler JR, Stawicki SPA. Methylene Blue and Dialysis-Related Hypotension. Hemodialysis - Different Aspects. InTech: Rijeka, Croatia; 2011. M.G. Penido, Editor."},{"issue":"1","key":"1133_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5527\/wjn.v5.i1.53","volume":"5","author":"M Kaur","year":"2016","unstructured":"Kaur M, et al. Baroreflex dysfunction in chronic kidney disease. World J Nephrol. 2016;5(1):53\u201365.","journal-title":"World J Nephrol"},{"issue":"1","key":"1133_CR25","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/s41598-019-39295-y","volume":"9","author":"S Park","year":"2019","unstructured":"Park S, et al. Predicting intradialytic hypotension using heart rate variability. Sci Rep. 2019;9(1):2574.","journal-title":"Sci Rep"},{"issue":"3","key":"1133_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1053\/j.ajkd.2015.03.028","volume":"66","author":"FR Mc Causland","year":"2015","unstructured":"Mc Causland FR, Waikar SS. Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline. Am J Kidney Dis. 2015;66(3):499\u2013506.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1133_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13613-021-00962-x","volume":"11","author":"EG Clark","year":"2021","unstructured":"Clark EG, et al. Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study). Ann Intensive Care. 2021;11(1):174.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"1133_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13054-020-03441-0","volume":"25","author":"E Macedo","year":"2021","unstructured":"Macedo E, et al. A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients. Crit Care. 2021;25(1):18.","journal-title":"Crit Care"},{"key":"1133_CR29","doi-asserted-by":"crossref","unstructured":"Feldman R et al. Can Albumin Trap Salicylate? An in vitro exploration of salicylate overdose scenarios. J Med Toxicol. 2025 ;22(1):29\u201338.","DOI":"10.1007\/s13181-025-01113-5"},{"issue":"6","key":"1133_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1197\/j.aem.2007.01.010","volume":"14","author":"SC Curry","year":"2007","unstructured":"Curry SC, et al. Effect of intravenous albumin infusion on brain salicylate concentration. Acad Emerg Med. 2007;14(6):508\u201314.","journal-title":"Acad Emerg Med"},{"issue":"2","key":"1133_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000341273","volume":"36","author":"FR Mc Causland","year":"2012","unstructured":"Mc Causland FR, et al. Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation. Am J Nephrol. 2012;36(2):168\u201374.","journal-title":"Am J Nephrol"},{"issue":"6","key":"1133_CR32","doi-asserted-by":"publisher","first-page":"712","DOI":"10.2215\/CJN.0000000000000431","volume":"19","author":"DC Miskulin","year":"2024","unstructured":"Miskulin DC, et al. Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial. Clin J Am Soc Nephrol. 2024;19(6):712\u201322.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1133_CR33","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1046\/j.1523-1755.2001.0590031175.x","volume":"59","author":"S Dheenan","year":"2001","unstructured":"Dheenan S, Henrich WL. Preventing dialysis hypotension: a comparison of usual protective maneuvers. Kidney Int. 2001;59(3):1175\u201381.","journal-title":"Kidney Int"},{"issue":"11","key":"1133_CR34","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1681\/ASN.V3111808","volume":"3","author":"R Gong","year":"1993","unstructured":"Gong R, et al. Comparison of hypertonic saline solutions and dextran in dialysis-induced hypotension. J Am Soc Nephrol. 1993;3(11):1808\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1133_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/ndt\/gfr272","volume":"27","author":"K Shimizu","year":"2012","unstructured":"Shimizu K, et al. Vasopressin secretion by hypertonic saline infusion during hemodialysis: effect of cardiopulmonary recirculation. Nephrol Dial Transpl. 2012;27(2):796\u2013803.","journal-title":"Nephrol Dial Transpl"},{"issue":"7","key":"1133_CR36","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/ndt\/16.7.1436","volume":"16","author":"G Peer","year":"2001","unstructured":"Peer G, et al. Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension. Nephrol Dial Transpl. 2001;16(7):1436\u201341.","journal-title":"Nephrol Dial Transpl"},{"key":"1133_CR37","doi-asserted-by":"crossref","unstructured":"DelBianco JD et al. Use of methylene blue to treat hypotension in poisoned patients in the toxicology investigators consortium (ToxIC) Core Registry: 2016\u20132023. J Med Toxicol, 2026;22(1):44\u201348.","DOI":"10.1007\/s13181-025-01103-7"},{"issue":"3","key":"1133_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2215\/CJN.04580415","volume":"11","author":"RA Mustafa","year":"2016","unstructured":"Mustafa RA, et al. Effect of Lowering the Dialysate Temperature in Chronic Hemodialysis: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2016;11(3):442\u201357.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1133_CR39","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2215\/CJN.02010606","volume":"1","author":"NM Selby","year":"2006","unstructured":"Selby NM, et al. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol. 2006;1(6):1216\u201325.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1133_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/ajkd.2002.34506","volume":"40","author":"Q Maggiore","year":"2002","unstructured":"Maggiore Q, et al. The effects of control of thermal balance on vascular stability in hemodialysis patients: results of the European randomized clinical trial. Am J Kidney Dis. 2002;40(2):280\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1133_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1681\/ASN.2013101086","volume":"26","author":"MT Eldehni","year":"2015","unstructured":"Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015;26(4):957\u201365.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1133_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13054-021-03585-7","volume":"25","author":"J Bouchard","year":"2021","unstructured":"Bouchard J, et al. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. Crit Care. 2021;25(1):201.","journal-title":"Crit Care"},{"issue":"2","key":"1133_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/ajkd.2001.21292","volume":"37","author":"R Alappan","year":"2001","unstructured":"Alappan R, et al. Treatment of Severe Intradialytic Hypotension With the Addition of High Dialysate Calcium Concentration to Midodrine and\/or Cool Dialysate. Am J Kidney Dis. 2001;37(2):294\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"1133_CR44","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.2215\/CJN.04470709","volume":"4","author":"JO Burton","year":"2009","unstructured":"Burton JO, et al. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009;4(12):1925\u201331.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1133_CR45","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1046\/j.1523-1755.2002.00100.x","volume":"61","author":"J Kyriazis","year":"2002","unstructured":"Kyriazis J, et al. Dialysate calcium profiling during hemodialysis: use and clinical implications. Kidney Int. 2002;61(1):276\u201387.","journal-title":"Kidney Int"},{"issue":"3","key":"1133_CR46","doi-asserted-by":"publisher","first-page":"358","DOI":"10.7326\/0003-4819-104-3-358","volume":"104","author":"JC Maynard","year":"1986","unstructured":"Maynard JC, et al. Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med. 1986;104(3):358\u201361.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1133_CR47","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1097\/CCM.0000000000002087","volume":"45","author":"M St-Onge","year":"2017","unstructured":"St-Onge M, et al. Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults. Crit Care Med. 2017;45(3):e306\u201315.","journal-title":"Crit Care Med"},{"key":"1133_CR48","doi-asserted-by":"publisher","first-page":"205435812096407","DOI":"10.1177\/2054358120964078","volume":"7","author":"A Varghese","year":"2020","unstructured":"Varghese A, et al. A Higher Concentration of Dialysate Magnesium to Reduce the Frequency of Muscle Cramps: A Narrative Review. Can J Kidney Health Dis. 2020;7:2054358120964078.","journal-title":"Can J Kidney Health Dis"},{"issue":"4","key":"1133_CR49","doi-asserted-by":"publisher","first-page":"sfaf072","DOI":"10.1093\/ckj\/sfaf072","volume":"18","author":"E Stamellou","year":"2025","unstructured":"Stamellou E, et al. 10 tips on how to manage severe arrhythmia in haemodialysis patients. Clin Kidney J. 2025;18(4):sfaf072.","journal-title":"Clin Kidney J"},{"issue":"12","key":"1133_CR50","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1007\/s12325-020-01505-9","volume":"37","author":"R Del Giorno","year":"2020","unstructured":"Del Giorno R, et al. Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase. Adv Ther. 2020;37(12):4848\u201365.","journal-title":"Adv Ther"},{"issue":"4","key":"1133_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00467-010-1654-3","volume":"26","author":"TE Bunchman","year":"2011","unstructured":"Bunchman TE, Ferris ME. Management of toxic ingestions with the use of renal replacement therapy. Pediatr Nephrol. 2011;26(4):535\u201341.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"1133_CR52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2215\/CJN.10000912","volume":"8","author":"PH Pun","year":"2013","unstructured":"Pun PH, Horton JR, Middleton JP. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(5):797\u2013803.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1133_CR53","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40620-019-00648-5","volume":"32","author":"V Pistolesi","year":"2019","unstructured":"Pistolesi V, et al. Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies. J Nephrol. 2019;32(6):895\u2013908.","journal-title":"J Nephrol"},{"key":"1133_CR54","unstructured":"Kaur J, Castro D. Hypophosphatemia, in StatPearls. 2024, StatPearls Publishing: Treasure Island (FL)."},{"issue":"3","key":"1133_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/hdi.12840","volume":"24","author":"K Vareesangthip","year":"2020","unstructured":"Vareesangthip K, Davenport A. Reducing the risk of intradialytic hypotension by altering the composition of the dialysate. Hemodial Int. 2020;24(3):276\u201381.","journal-title":"Hemodial Int"},{"issue":"3","key":"1133_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40264-019-00888-1","volume":"43","author":"E Megapanou","year":"2020","unstructured":"Megapanou E, et al. Drug-Induced Hypophosphatemia: Current Insights. Drug Saf. 2020;43(3):197\u2013210.","journal-title":"Drug Saf"},{"issue":"7","key":"1133_CR57","doi-asserted-by":"publisher","first-page":"e0271307","DOI":"10.1371\/journal.pone.0271307","volume":"17","author":"A Chewcharat","year":"2022","unstructured":"Chewcharat A, et al. The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis. PLoS ONE. 2022;17(7):e0271307.","journal-title":"PLoS ONE"},{"issue":"2","key":"1133_CR58","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.ajkd.2015.09.010","volume":"67","author":"T Higuchi","year":"2016","unstructured":"Higuchi T, et al. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial. Am J Kidney Dis. 2016;67(2):260\u201370.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1133_CR59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000355016","volume":"3","author":"Y Kudoh","year":"2013","unstructured":"Kudoh Y, et al. Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients. Cardiorenal Med. 2013;3(3):200\u20137.","journal-title":"Cardiorenal Med"},{"issue":"3","key":"1133_CR60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1185\/030079902125000606","volume":"18","author":"GF Romagnoli","year":"2002","unstructured":"Romagnoli GF, et al. Beneficial effects of L-carnitine in dialysis patients with impaired left ventricular function: an observational study. Curr Med Res Opin. 2002;18(3):172\u20135.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"1133_CR61","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1553-2712.2011.01217.x","volume":"18","author":"E Perez","year":"2011","unstructured":"Perez E, et al. L-carnitine increases survival in a murine model of severe verapamil toxicity. Acad Emerg Med. 2011;18(11):1135\u201340.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"1133_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13054-025-05330-w","volume":"29","author":"JX Geerdink","year":"2025","unstructured":"Geerdink JX, et al. Sodium azide (NaN3) intoxication, the man who lived: potential effective antidote and treatment strategy. Crit Care. 2025;29(1):103.","journal-title":"Crit Care"},{"issue":"10","key":"1133_CR63","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/ndt\/gfh420","volume":"19","author":"S Prakash","year":"2004","unstructured":"Prakash S, et al. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. Nephrol Dial Transpl. 2004;19(10):2553\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"1133_CR64","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2020.01.046","volume":"97","author":"JE Flythe","year":"2020","unstructured":"Flythe JE, et al. Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020;97(5):861\u201376.","journal-title":"Kidney Int"},{"key":"1133_CR65","unstructured":"Chiu WY et al. Intradialytic dopamine therapy in maintenance hemodialysis patients with persistent hypotension. 2007;21(1):22\u201329."},{"issue":"4","key":"1133_CR66","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000013498","volume":"19","author":"U Anand","year":"1999","unstructured":"Anand U, et al. Intradialytic dobutamine therapy in maintenance hemodialysis patients with persistent hypotension. Am J Nephrol. 1999;19(4):459\u201363.","journal-title":"Am J Nephrol"},{"issue":"5","key":"1133_CR67","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1525-139X.2009.00615.x","volume":"22","author":"AM Thompson","year":"2009","unstructured":"Thompson AM, Oliver JA. Endogenous and exogenous vasopressin during hemodialysis. Semin Dial. 2009;22(5):472\u20135.","journal-title":"Semin Dial"},{"issue":"4","key":"1133_CR68","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/sj.ki.5001885","volume":"71","author":"S van der Zee","year":"2007","unstructured":"van der Zee S, et al. Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int. 2007;71(4):318\u201324.","journal-title":"Kidney Int"},{"issue":"3","key":"1133_CR69","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13181-025-01069-6","volume":"21","author":"HH Spungen","year":"2025","unstructured":"Spungen HH, et al. Vasopressor Use, Critical Care Management, and Outcomes in Dihydropyridine Calcium Channel Blocker Toxicity. J Med Toxicol. 2025;21(3):304\u201311.","journal-title":"J Med Toxicol"},{"issue":"10","key":"1133_CR70","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/15563650.2021.1945082","volume":"59","author":"C Upchurch","year":"2021","unstructured":"Upchurch C, et al. Extracorporeal membrane oxygenation use in poisoning: a narrative review with clinical recommendations. Clin Toxicol (Phila). 2021;59(10):877\u201387.","journal-title":"Clin Toxicol (Phila)"},{"issue":"5","key":"1133_CR71","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/15563650.2013.800876","volume":"51","author":"DW de Lange","year":"2013","unstructured":"de Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila). 2013;51(5):385\u201393.","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"1133_CR72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MAT.0000000000000441","volume":"63","author":"C de Tymowski","year":"2017","unstructured":"de Tymowski C, et al. CRRT Connected to ECMO: Managing High Pressures. Asaio j. 2017;63(1):48\u201352.","journal-title":"Asaio j"},{"issue":"7","key":"1133_CR73","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/15563650.2019.1676896","volume":"58","author":"L Weiner","year":"2020","unstructured":"Weiner L, et al. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations\u2019 ECMO case registry. Clin Toxicol (Phila). 2020;58(7):705\u201310.","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"1133_CR74","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/1744-9987.13967","volume":"27","author":"M Avci","year":"2023","unstructured":"Avci M, Arikan F. The effect of food intake during hemodialysis on blood pressure: A nonrandomized experimental trial. Ther Apher Dial. 2023;27(4):661\u20138.","journal-title":"Ther Apher Dial"},{"issue":"3","key":"1133_CR75","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3904\/kjim.2017.020","volume":"34","author":"SY Rhee","year":"2019","unstructured":"Rhee SY, et al. Intradialytic exercise improves physical function and reduces intradialytic hypotension and depression in hemodialysis patients. Korean J Intern Med. 2019;34(3):588\u201398.","journal-title":"Korean J Intern Med"},{"issue":"5","key":"1133_CR76","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ekir.2023.02.1074","volume":"8","author":"K Rossum","year":"2023","unstructured":"Rossum K, et al. A Randomized Trial Examining the Impact of Timing of Intradialytic Cycling on Intradialytic Hypotension. Kidney Int Rep. 2023;8(5):1002\u201312.","journal-title":"Kidney Int Rep"},{"issue":"11","key":"1133_CR77","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1681\/ASN.V3111813","volume":"3","author":"MM Barakat","year":"1993","unstructured":"Barakat MM, et al. Hemodynamic effects of intradialytic food ingestion and the effects of caffeine. J Am Soc Nephrol. 1993;3(11):1813\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1133_CR78","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1590\/2175-8239-jbn-2018-0189","volume":"41","author":"C Molin","year":"2019","unstructured":"Molin C, et al. Effects of sertraline in the prevention of low blood pressure in patients undergoing hemodialysis. J Bras Nefrol. 2019;41(4):492\u2013500.","journal-title":"J Bras Nefrol"},{"issue":"4","key":"1133_CR79","first-page":"323","volume":"9","author":"E Razeghi","year":"2015","unstructured":"Razeghi E, et al. A randomized crossover clinical trial of sertraline for intradialytic hypotension. Iran J Kidney Dis. 2015;9(4):323\u201330.","journal-title":"Iran J Kidney Dis"},{"issue":"2","key":"1133_CR80","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/00325481.2015.1015393","volume":"127","author":"MD Vannorsdall","year":"2015","unstructured":"Vannorsdall MD, Hariachar S, Hewitt LA. A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension. Postgrad Med. 2015;127(2):133\u201343.","journal-title":"Postgrad Med"},{"issue":"3","key":"1133_CR81","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000527608","volume":"52","author":"T Vongchaiudomchoke","year":"2023","unstructured":"Vongchaiudomchoke T, et al. Effect of Fludrocortisone on Intradialytic Hypotension: An Open-Label, Randomized, Crossover Study. Blood Purif. 2023;52(3):264\u201374.","journal-title":"Blood Purif"},{"issue":"7","key":"1133_CR82","doi-asserted-by":"publisher","first-page":"100840","DOI":"10.1016\/j.xkme.2024.100840","volume":"6","author":"YH Chen","year":"2024","unstructured":"Chen YH, Chen CT. Atomoxetine for Intradialytic Hypotension in a Patient on Hemodialysis: A Case Report. Kidney Med. 2024;6(7):100840.","journal-title":"Kidney Med"},{"issue":"3","key":"1133_CR83","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/hdi.12488","volume":"21","author":"N Dunne","year":"2017","unstructured":"Dunne N. A meta-analysis of sodium profiling techniques and the impact on intradialytic hypotension. Hemodial Int. 2017;21(3):312\u201322.","journal-title":"Hemodial Int"},{"issue":"10","key":"1133_CR84","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/nep.12677","volume":"21","author":"KE Lynch","year":"2016","unstructured":"Lynch KE, et al. Sodium modelling to reduce intradialytic hypotension during haemodialysis for acute kidney injury in the intensive care unit. Nephrol (Carlton). 2016;21(10):870\u20137.","journal-title":"Nephrol (Carlton)"},{"issue":"2","key":"1133_CR85","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/hdi.12138","volume":"18","author":"JJ Sands","year":"2014","unstructured":"Sands JJ, et al. Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int. 2014;18(2):415\u201322.","journal-title":"Hemodial Int"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01133-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-026-01133-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-026-01133-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:16:46Z","timestamp":1785521806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-026-01133-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1007\/s13181-026-01133-9","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is a narrative review of previously published data and does not contain any studies with human participants or animals performed by any of the authors. For this type of study, formal institutional review board or ethics committee approval and informed consent are not required.","order":1,"name":"Ethics","label":"Ethics Statement \/ Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"David K. Carroll, Andrew M. King, Andrew Isaacson, Brandtly Yakey, Aria Darling, Varun Vohra, and Josh D. King declare that they have no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}